Benitec Biopharma Inc.BNTCNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P44
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -13.01% |
| Q3 2025 | 60.71% |
| Q2 2025 | -175.84% |
| Q1 2025 | 59.92% |
| Q4 2024 | -68.23% |
| Q3 2024 | -39.27% |
| Q2 2024 | 48.68% |
| Q1 2024 | -20.32% |
| Q4 2023 | -16.53% |
| Q3 2023 | -19.28% |
| Q2 2023 | 4.76% |
| Q1 2023 | 0.00% |
| Q4 2022 | 100.00% |
| Q3 2022 | 14.48% |
| Q2 2022 | -38.22% |
| Q1 2022 | -2.33% |
| Q4 2021 | 21.83% |
| Q3 2021 | 14.71% |
| Q2 2021 | -150.30% |
| Q1 2021 | 42.74% |
| Q4 2020 | -38.18% |
| Q3 2020 | 19.79% |
| Q2 2020 | -395.05% |
| Q1 2020 | 79.76% |
| Q4 2019 | -174.80% |
| Q3 2019 | -904.77% |
| Q2 2019 | 56.52% |
| Q1 2019 | 85.25% |
| Q4 2018 | -130.46% |
| Q3 2018 | 399.53% |
| Q2 2018 | 5.62% |
| Q1 2018 | 51.91% |
| Q4 2017 | -63.38% |
| Q3 2017 | -18.03% |
| Q2 2017 | -205.55% |
| Q1 2017 | 156.68% |
| Q4 2016 | 18.85% |
| Q3 2016 | -148.26% |
| Q2 2016 | 54.61% |
| Q1 2016 | 44.45% |